Lanadelumab’s Enduring Effectiveness and Safety in the Management of Hereditary Angioedema for Patients from Puerto Rico: Data from EMPOWER
Findings from this analysis support the clinical benefits and safety of lanadelumab treatment for HAE prophylaxis in patients from Puerto Rico.
Authors
- Rafael Zaragoza-Urdaz
- Salomé Juethner
- Daniel N. Castaner
- Daniel Fox
- Tyrone McBayne
- Natalie Khutoryansky
- Paula J. Busse
Publication Details
- Journal
- International Archives of Allergy and Immunology
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1159/000550883
- Primary Topic
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Type
- article
- Field-Weighted Citation Impact
- 0.00